Patent ID: 11965028
Assignee: THERANOVIR
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The antibody or antibody fragment of claim 1 comprising
a heavy chain of SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, SEQ ID NO: 46, SEQ ID NO: 47 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 40-47, and
a light chain of SEQ ID No: 48, SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 52, SEQ ID NO: 53 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 48-53.